The Sanger Institute will move from a patchwork of legacy LIMS solutions to a foundation centered on Sapio LIMS to support large-scale genomic research, demand planning and lab operations.
The multi-year digital transformation project is led by the Sanger Institute's Core Operations team, which sits at the heart of the Institute. Core Operations provides a broad range of cellular and genomic workflows that underpin the Institute’s end-to-end research and data-generation processes. Currently, the Core Operations team utilizes digital tools and technology solutions that have been developed to address specific workflow needs, including sample management, storage, planning and lab execution.
This patchwork of solutions and technologies has made it harder to coordinate work across teams, plan work from start to finish, and provide visibility of progress to scientists.
One of the initial goals of the transformation is to give Core Operations and scientific teams a clearer view of work coming into the lab, how that work moves through complex pipelines, resources that are required at each step, and provide access to key scientific data generated throughout the processing pipelines to scientists.
In addition to implementing a dominant LIMS to underpin the research conducted by the Sanger Institute, the transformation will focus on the workflows, data, and instruments used across the Cellular Platforms and Genomic Platforms teams and eventually extend across all research teams.
“Sapio Sciences is honored to work alongside the Wellcome Sanger Institute as they continue shaping the future of genomic science,” said Mike Hampton, Chief Commercial Officer at Sapio Sciences. “Sanger helped set the standard for large-scale genomics, and they have very clear expectations for their scientific enablement. With this project,
we will work together to put Sapio LIMS at the center of their lab operations, cut out avoidable friction in day-to-day work, and give teams better visibility of the data, workflows and resources that drive their science.”
“Giving our scientists clear, reliable answers to ‘Where is my sample and where is my data?’ across complex, multi-team workflows is one of our biggest challenges,” said Simon Moore, COO at the Wellcome Sanger Institute. “To plan and deliver their research, our scientists need confidence that sample progress and critical data are always visible and accessible.
By moving to Sapio LIMS as our core platform, we can improve how we track, manage and orchestrate work; align resources; and streamline workflows. Sapio gives our scientists modern, configurable tools that keep pace with the way we do science.”
Taken together, the program is intended to give the Sanger Institute a clearer view of data generation progress, demand, capacity and scientific work across its labs; remove avoidable complexity from daily operations; and support faster, more reliable delivery of genomic science.
About Sapio Sciences
At Sapio Sciences, our mission is to improve lives by accelerating the entire drug lifecycle. Our configurable, AI-native informatics platform, including LIMS, Sapio ELaiN (the world’s first AI Lab Notebook), and Scientific Data Cloud, streamlines complex workflows, unifies scientific data, and enables faster, smarter decisions across biopharma research and development, clinical diagnostics, and manufacturing.
Trusted by global leaders and innovators worldwide, we support a wide range of best-in-class applications, from NGS, bioanalysis and bioprocessing to stability studies, histopathology, antibody discovery, and in vivo studies.
The Wellcome Sanger Institute
The Wellcome Sanger Institute is a world leader in genomics research. We apply and explore genomic technologies at scale to advance understanding of biology and improve health. Making discoveries not easily made elsewhere, our research delivers insights across health, disease, evolution and pathogen biology. We are open and collaborative; our data, results, tools, technologies and training are freely shared across the globe to advance science.
Funded by Wellcome, we have the freedom to think long-term and push the boundaries of genomics. We take on the challenges of applying our research to the real world, where we aim to bring benefit to people and society.
For more information please visit, www.sanger.ac.uk
